UK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ...

Q4 2024 Results Conference Call March 19, 2025 8:30 AM ETCompany ParticipantsDan Ferry - IR, LifeSci AdvisorsOfer Gonen - ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...

The rare flesh-eating condition is known as periorbital necrotizing soft tissue infection, and is caused by either ...

Stephanie Coral Browitt escaped death following the 2019 White Island eruption. After recovering for years from third-degree burns that covered 70 percent of her body and eight finger amputations, she ...

The first patient developed a fatal infection after showing up at a hospital in Germany with swelling around his left eyelid ...

SolasCure, a Cambridge biotech developing a novel treatment to transform chronic wound healing, has initiated a new Phase II ...

Reported positive results from the Expanded Access Protocol (NEXT), reinforcing NexoBrid's clinical and real-world benefits across 29 burn centers in the U.S. The study included 239 patients (215 ...

Three men have been hit by a rare and gruesome flesh-eating bug, with one of them tragically losing his life to the ...

Stan "The Fan" Charles weighs in on the Orioles' injuries and his own, with fingers crossed that better health is on the way ...

Medical honey proves effective against antibiotic-resistant bacteria, transforming wound care and offering hope in the fight ...

Hunt School of Dental Medicine students provide crucial oral health care to adults over 60 with the help of community ...